img

Global Complement Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Complement Drug Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Complement Drug Market
The global Complement Drug market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Complement Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Complement Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Complement Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Complement Drug include Novartis AG, Alexion Pharmaceuticals, ChemoCentryx, Roche, Apellis, Regeneron, Amgen, Alnylam and UCB, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Complement Drug market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Complement Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Complement Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Complement Drug revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Complement Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Complement Drug revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis AG, Alexion Pharmaceuticals, ChemoCentryx, Roche, Apellis, Regeneron, Amgen, Alnylam and UCB, etc.



By Company


Novartis AG
Alexion Pharmaceuticals
ChemoCentryx
Roche
Apellis
Regeneron
Amgen
Alnylam
UCB
InflaRx
ChemoCentryx
Innate Pharma
Ionis Pharmaceuticals
Avant Immunotherapeutics
Pfizer
Sanofi
Omeros
GenMab
Akari Therapeutics
AbbVie
Segment by Type
Peptides
Antibodies
Others

Segment by Application


Blood Disease
Kidney Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Complement Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Complement Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Complement Drug revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Complement Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Peptides
1.2.3 Antibodies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Complement Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Blood Disease
1.3.3 Kidney Disease
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Complement Drug Market Perspective (2018-2034)
2.2 Global Complement Drug Growth Trends by Region
2.2.1 Complement Drug Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Complement Drug Historic Market Size by Region (2018-2024)
2.2.3 Complement Drug Forecasted Market Size by Region (2024-2034)
2.3 Complement Drug Market Dynamics
2.3.1 Complement Drug Industry Trends
2.3.2 Complement Drug Market Drivers
2.3.3 Complement Drug Market Challenges
2.3.4 Complement Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Complement Drug by Players
3.1.1 Global Complement Drug Revenue by Players (2018-2024)
3.1.2 Global Complement Drug Revenue Market Share by Players (2018-2024)
3.2 Global Complement Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Complement Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Complement Drug Market Concentration Ratio
3.4.1 Global Complement Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Complement Drug Revenue in 2022
3.5 Global Key Players of Complement Drug Head office and Area Served
3.6 Global Key Players of Complement Drug, Product and Application
3.7 Global Key Players of Complement Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Complement Drug Breakdown Data by Type
4.1 Global Complement Drug Historic Market Size by Type (2018-2024)
4.2 Global Complement Drug Forecasted Market Size by Type (2024-2034)
5 Complement Drug Breakdown Data by Application
5.1 Global Complement Drug Historic Market Size by Application (2018-2024)
5.2 Global Complement Drug Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Complement Drug Market Size (2018-2034)
6.2 North America Complement Drug Market Size by Type
6.2.1 North America Complement Drug Market Size by Type (2018-2024)
6.2.2 North America Complement Drug Market Size by Type (2024-2034)
6.2.3 North America Complement Drug Market Share by Type (2018-2034)
6.3 North America Complement Drug Market Size by Application
6.3.1 North America Complement Drug Market Size by Application (2018-2024)
6.3.2 North America Complement Drug Market Size by Application (2024-2034)
6.3.3 North America Complement Drug Market Share by Application (2018-2034)
6.4 North America Complement Drug Market Size by Country
6.4.1 North America Complement Drug Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Complement Drug Market Size by Country (2018-2024)
6.4.3 North America Complement Drug Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Complement Drug Market Size (2018-2034)
7.2 Europe Complement Drug Market Size by Type
7.2.1 Europe Complement Drug Market Size by Type (2018-2024)
7.2.2 Europe Complement Drug Market Size by Type (2024-2034)
7.2.3 Europe Complement Drug Market Share by Type (2018-2034)
7.3 Europe Complement Drug Market Size by Application
7.3.1 Europe Complement Drug Market Size by Application (2018-2024)
7.3.2 Europe Complement Drug Market Size by Application (2024-2034)
7.3.3 Europe Complement Drug Market Share by Application (2018-2034)
7.4 Europe Complement Drug Market Size by Country
7.4.1 Europe Complement Drug Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Complement Drug Market Size by Country (2018-2024)
7.4.3 Europe Complement Drug Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Complement Drug Market Size (2018-2034)
8.2 China Complement Drug Market Size by Type
8.2.1 China Complement Drug Market Size by Type (2018-2024)
8.2.2 China Complement Drug Market Size by Type (2024-2034)
8.2.3 China Complement Drug Market Share by Type (2018-2034)
8.3 China Complement Drug Market Size by Application
8.3.1 China Complement Drug Market Size by Application (2018-2024)
8.3.2 China Complement Drug Market Size by Application (2024-2034)
8.3.3 China Complement Drug Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Complement Drug Market Size (2018-2034)
9.2 Asia Complement Drug Market Size by Type
9.2.1 Asia Complement Drug Market Size by Type (2018-2024)
9.2.2 Asia Complement Drug Market Size by Type (2024-2034)
9.2.3 Asia Complement Drug Market Share by Type (2018-2034)
9.3 Asia Complement Drug Market Size by Application
9.3.1 Asia Complement Drug Market Size by Application (2018-2024)
9.3.2 Asia Complement Drug Market Size by Application (2024-2034)
9.3.3 Asia Complement Drug Market Share by Application (2018-2034)
9.4 Asia Complement Drug Market Size by Region
9.4.1 Asia Complement Drug Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Complement Drug Market Size by Region (2018-2024)
9.4.3 Asia Complement Drug Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Complement Drug Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Complement Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Complement Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Complement Drug Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Complement Drug Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Complement Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Complement Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Complement Drug Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Complement Drug Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Complement Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Complement Drug Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Complement Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Complement Drug Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Complement Drug Introduction
11.1.4 Novartis AG Revenue in Complement Drug Business (2018-2024)
11.1.5 Novartis AG Recent Developments
11.2 Alexion Pharmaceuticals
11.2.1 Alexion Pharmaceuticals Company Details
11.2.2 Alexion Pharmaceuticals Business Overview
11.2.3 Alexion Pharmaceuticals Complement Drug Introduction
11.2.4 Alexion Pharmaceuticals Revenue in Complement Drug Business (2018-2024)
11.2.5 Alexion Pharmaceuticals Recent Developments
11.3 ChemoCentryx
11.3.1 ChemoCentryx Company Details
11.3.2 ChemoCentryx Business Overview
11.3.3 ChemoCentryx Complement Drug Introduction
11.3.4 ChemoCentryx Revenue in Complement Drug Business (2018-2024)
11.3.5 ChemoCentryx Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Complement Drug Introduction
11.4.4 Roche Revenue in Complement Drug Business (2018-2024)
11.4.5 Roche Recent Developments
11.5 Apellis
11.5.1 Apellis Company Details
11.5.2 Apellis Business Overview
11.5.3 Apellis Complement Drug Introduction
11.5.4 Apellis Revenue in Complement Drug Business (2018-2024)
11.5.5 Apellis Recent Developments
11.6 Regeneron
11.6.1 Regeneron Company Details
11.6.2 Regeneron Business Overview
11.6.3 Regeneron Complement Drug Introduction
11.6.4 Regeneron Revenue in Complement Drug Business (2018-2024)
11.6.5 Regeneron Recent Developments
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Complement Drug Introduction
11.7.4 Amgen Revenue in Complement Drug Business (2018-2024)
11.7.5 Amgen Recent Developments
11.8 Alnylam
11.8.1 Alnylam Company Details
11.8.2 Alnylam Business Overview
11.8.3 Alnylam Complement Drug Introduction
11.8.4 Alnylam Revenue in Complement Drug Business (2018-2024)
11.8.5 Alnylam Recent Developments
11.9 UCB
11.9.1 UCB Company Details
11.9.2 UCB Business Overview
11.9.3 UCB Complement Drug Introduction
11.9.4 UCB Revenue in Complement Drug Business (2018-2024)
11.9.5 UCB Recent Developments
11.10 InflaRx
11.10.1 InflaRx Company Details
11.10.2 InflaRx Business Overview
11.10.3 InflaRx Complement Drug Introduction
11.10.4 InflaRx Revenue in Complement Drug Business (2018-2024)
11.10.5 InflaRx Recent Developments
11.11 ChemoCentryx
11.11.1 ChemoCentryx Company Details
11.11.2 ChemoCentryx Business Overview
11.11.3 ChemoCentryx Complement Drug Introduction
11.11.4 ChemoCentryx Revenue in Complement Drug Business (2018-2024)
11.11.5 ChemoCentryx Recent Developments
11.12 Innate Pharma
11.12.1 Innate Pharma Company Details
11.12.2 Innate Pharma Business Overview
11.12.3 Innate Pharma Complement Drug Introduction
11.12.4 Innate Pharma Revenue in Complement Drug Business (2018-2024)
11.12.5 Innate Pharma Recent Developments
11.13 Ionis Pharmaceuticals
11.13.1 Ionis Pharmaceuticals Company Details
11.13.2 Ionis Pharmaceuticals Business Overview
11.13.3 Ionis Pharmaceuticals Complement Drug Introduction
11.13.4 Ionis Pharmaceuticals Revenue in Complement Drug Business (2018-2024)
11.13.5 Ionis Pharmaceuticals Recent Developments
11.14 Avant Immunotherapeutics
11.14.1 Avant Immunotherapeutics Company Details
11.14.2 Avant Immunotherapeutics Business Overview
11.14.3 Avant Immunotherapeutics Complement Drug Introduction
11.14.4 Avant Immunotherapeutics Revenue in Complement Drug Business (2018-2024)
11.14.5 Avant Immunotherapeutics Recent Developments
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Complement Drug Introduction
11.15.4 Pfizer Revenue in Complement Drug Business (2018-2024)
11.15.5 Pfizer Recent Developments
11.16 Sanofi
11.16.1 Sanofi Company Details
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Complement Drug Introduction
11.16.4 Sanofi Revenue in Complement Drug Business (2018-2024)
11.16.5 Sanofi Recent Developments
11.17 Omeros
11.17.1 Omeros Company Details
11.17.2 Omeros Business Overview
11.17.3 Omeros Complement Drug Introduction
11.17.4 Omeros Revenue in Complement Drug Business (2018-2024)
11.17.5 Omeros Recent Developments
11.18 GenMab
11.18.1 GenMab Company Details
11.18.2 GenMab Business Overview
11.18.3 GenMab Complement Drug Introduction
11.18.4 GenMab Revenue in Complement Drug Business (2018-2024)
11.18.5 GenMab Recent Developments
11.19 Akari Therapeutics
11.19.1 Akari Therapeutics Company Details
11.19.2 Akari Therapeutics Business Overview
11.19.3 Akari Therapeutics Complement Drug Introduction
11.19.4 Akari Therapeutics Revenue in Complement Drug Business (2018-2024)
11.19.5 Akari Therapeutics Recent Developments
11.20 AbbVie
11.20.1 AbbVie Company Details
11.20.2 AbbVie Business Overview
11.20.3 AbbVie Complement Drug Introduction
11.20.4 AbbVie Revenue in Complement Drug Business (2018-2024)
11.20.5 AbbVie Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Complement Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Peptides
Table 3. Key Players of Antibodies
Table 4. Key Players of Others
Table 5. Global Complement Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 6. Global Complement Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Complement Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Complement Drug Market Share by Region (2018-2024)
Table 9. Global Complement Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Complement Drug Market Share by Region (2024-2034)
Table 11. Complement Drug Market Trends
Table 12. Complement Drug Market Drivers
Table 13. Complement Drug Market Challenges
Table 14. Complement Drug Market Restraints
Table 15. Global Complement Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Complement Drug Revenue Share by Players (2018-2024)
Table 17. Global Top Complement Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2022)
Table 18. Global Complement Drug Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Complement Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Complement Drug, Headquarters and Area Served
Table 21. Global Key Players of Complement Drug, Product and Application
Table 22. Global Key Players of Complement Drug, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Complement Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Complement Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Complement Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Complement Drug Revenue Market Share by Type (2024-2034)
Table 28. Global Complement Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Complement Drug Revenue Share by Application (2018-2024)
Table 30. Global Complement Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Complement Drug Revenue Share by Application (2024-2034)
Table 32. North America Complement Drug Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Complement Drug Market Size by Type (2024-2034) & (US$ Million)
Table 34. North America Complement Drug Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Complement Drug Market Size by Application (2024-2034) & (US$ Million)
Table 36. North America Complement Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 37. North America Complement Drug Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Complement Drug Market Size by Country (2024-2034) & (US$ Million)
Table 39. Europe Complement Drug Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Complement Drug Market Size by Type (2024-2034) & (US$ Million)
Table 41. Europe Complement Drug Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Complement Drug Market Size by Application (2024-2034) & (US$ Million)
Table 43. Europe Complement Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 44. Europe Complement Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Complement Drug Market Size by Country (2024-2034) & (US$ Million)
Table 46. China Complement Drug Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Complement Drug Market Size by Type (2024-2034) & (US$ Million)
Table 48. China Complement Drug Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Complement Drug Market Size by Application (2024-2034) & (US$ Million)
Table 50. Asia Complement Drug Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Complement Drug Market Size by Type (2024-2034) & (US$ Million)
Table 52. Asia Complement Drug Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Complement Drug Market Size by Application (2024-2034) & (US$ Million)
Table 54. Asia Complement Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 55. Asia Complement Drug Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Complement Drug Market Size by Region (2024-2034) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Complement Drug Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Complement Drug Market Size by Type (2024-2034) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Complement Drug Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Complement Drug Market Size by Application (2024-2034) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Complement Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 62. Middle East, Africa, and Latin America Complement Drug Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Complement Drug Market Size by Country (2024-2034) & (US$ Million)
Table 64. Novartis AG Company Details
Table 65. Novartis AG Business Overview
Table 66. Novartis AG Complement Drug Product
Table 67. Novartis AG Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 68. Novartis AG Recent Developments
Table 69. Alexion Pharmaceuticals Company Details
Table 70. Alexion Pharmaceuticals Business Overview
Table 71. Alexion Pharmaceuticals Complement Drug Product
Table 72. Alexion Pharmaceuticals Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 73. Alexion Pharmaceuticals Recent Developments
Table 74. ChemoCentryx Company Details
Table 75. ChemoCentryx Business Overview
Table 76. ChemoCentryx Complement Drug Product
Table 77. ChemoCentryx Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 78. ChemoCentryx Recent Developments
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Complement Drug Product
Table 82. Roche Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 83. Roche Recent Developments
Table 84. Apellis Company Details
Table 85. Apellis Business Overview
Table 86. Apellis Complement Drug Product
Table 87. Apellis Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 88. Apellis Recent Developments
Table 89. Regeneron Company Details
Table 90. Regeneron Business Overview
Table 91. Regeneron Complement Drug Product
Table 92. Regeneron Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 93. Regeneron Recent Developments
Table 94. Amgen Company Details
Table 95. Amgen Business Overview
Table 96. Amgen Complement Drug Product
Table 97. Amgen Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 98. Amgen Recent Developments
Table 99. Alnylam Company Details
Table 100. Alnylam Business Overview
Table 101. Alnylam Complement Drug Product
Table 102. Alnylam Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 103. Alnylam Recent Developments
Table 104. UCB Company Details
Table 105. UCB Business Overview
Table 106. UCB Complement Drug Product
Table 107. UCB Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 108. UCB Recent Developments
Table 109. InflaRx Company Details
Table 110. InflaRx Business Overview
Table 111. InflaRx Complement Drug Product
Table 112. InflaRx Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 113. InflaRx Recent Developments
Table 114. ChemoCentryx Company Details
Table 115. ChemoCentryx Business Overview
Table 116. ChemoCentryx Complement Drug Product
Table 117. ChemoCentryx Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 118. ChemoCentryx Recent Developments
Table 119. Innate Pharma Company Details
Table 120. Innate Pharma Business Overview
Table 121. Innate Pharma Complement Drug Product
Table 122. Innate Pharma Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 123. Innate Pharma Recent Developments
Table 124. Ionis Pharmaceuticals Company Details
Table 125. Ionis Pharmaceuticals Business Overview
Table 126. Ionis Pharmaceuticals Complement Drug Product
Table 127. Ionis Pharmaceuticals Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 128. Ionis Pharmaceuticals Recent Developments
Table 129. Avant Immunotherapeutics Company Details
Table 130. Avant Immunotherapeutics Business Overview
Table 131. Avant Immunotherapeutics Complement Drug Product
Table 132. Avant Immunotherapeutics Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 133. Avant Immunotherapeutics Recent Developments
Table 134. Pfizer Company Details
Table 135. Pfizer Business Overview
Table 136. Pfizer Complement Drug Product
Table 137. Pfizer Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 138. Pfizer Recent Developments
Table 139. Sanofi Company Details
Table 140. Sanofi Business Overview
Table 141. Sanofi Complement Drug Product
Table 142. Sanofi Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 143. Sanofi Recent Developments
Table 144. Omeros Company Details
Table 145. Omeros Business Overview
Table 146. Omeros Complement Drug Product
Table 147. Omeros Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 148. Omeros Recent Developments
Table 149. GenMab Company Details
Table 150. GenMab Business Overview
Table 151. GenMab Complement Drug Product
Table 152. GenMab Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 153. GenMab Recent Developments
Table 154. Akari Therapeutics Company Details
Table 155. Akari Therapeutics Business Overview
Table 156. Akari Therapeutics Complement Drug Product
Table 157. Akari Therapeutics Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 158. Akari Therapeutics Recent Developments
Table 159. AbbVie Company Details
Table 160. AbbVie Business Overview
Table 161. AbbVie Complement Drug Product
Table 162. AbbVie Revenue in Complement Drug Business (2018-2024) & (US$ Million)
Table 163. AbbVie Recent Developments
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Complement Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Complement Drug Market Share by Type: 2022 VS 2034
Figure 3. Peptides Features
Figure 4. Antibodies Features
Figure 5. Others Features
Figure 6. Global Complement Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Complement Drug Market Share by Application: 2022 VS 2034
Figure 8. Blood Disease Case Studies
Figure 9. Kidney Disease Case Studies
Figure 10. Others Case Studies
Figure 11. Complement Drug Report Years Considered
Figure 12. Global Complement Drug Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Complement Drug Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Complement Drug Market Share by Region: 2022 VS 2034
Figure 15. Global Complement Drug Market Share by Players in 2022
Figure 16. Global Top Complement Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Complement Drug Revenue in 2022
Figure 18. North America Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Complement Drug Market Share by Type (2018-2034)
Figure 20. North America Complement Drug Market Share by Application (2018-2034)
Figure 21. North America Complement Drug Market Share by Country (2018-2034)
Figure 22. United States Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Complement Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 25. Europe Complement Drug Market Share by Type (2018-2034)
Figure 26. Europe Complement Drug Market Share by Application (2018-2034)
Figure 27. Europe Complement Drug Market Share by Country (2018-2034)
Figure 28. Germany Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. France Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. U.K. Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Italy Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Russia Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Nordic Countries Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. China Complement Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 35. China Complement Drug Market Share by Type (2018-2034)
Figure 36. China Complement Drug Market Share by Application (2018-2034)
Figure 37. Asia Complement Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 38. Asia Complement Drug Market Share by Type (2018-2034)
Figure 39. Asia Complement Drug Market Share by Application (2018-2034)
Figure 40. Asia Complement Drug Market Share by Region (2018-2034)
Figure 41. Japan Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. South Korea Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. China Taiwan Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Southeast Asia Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. India Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Australia Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Complement Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Complement Drug Market Share by Type (2018-2034)
Figure 49. Middle East, Africa, and Latin America Complement Drug Market Share by Application (2018-2034)
Figure 50. Middle East, Africa, and Latin America Complement Drug Market Share by Country (2018-2034)
Figure 51. Brazil Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Mexico Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Turkey Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Israel Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. GCC Countries Complement Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. Novartis AG Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 58. Alexion Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 59. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 60. Roche Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 61. Apellis Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 62. Regeneron Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 63. Amgen Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 64. Alnylam Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 65. UCB Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 66. InflaRx Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 67. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 68. Innate Pharma Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 69. Ionis Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 70. Avant Immunotherapeutics Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 71. Pfizer Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 72. Sanofi Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 73. Omeros Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 74. GenMab Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 75. Akari Therapeutics Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 76. AbbVie Revenue Growth Rate in Complement Drug Business (2018-2024)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries